What do we know about extracellular vesicles in patients with idiopathic pulmonary fibrosis? a scoping review

QR Code

What do we know about extracellular vesicles in patients with idiopathic pulmonary fibrosis? a scoping review

Extracellular Vesicles (EVs), released by all cell types and detectable in biological samples, carry a variety of biological molecules. These molecules mediate communication and signaling with both local and distant cells, potentially playing a role in the pathogenesis of diseases, including Interst...

Full description

Saved in:

Bibliographic Details
Main Authors:	Maria Conti, Alvise Casara, Graziella Turato, Simonetta Baraldo, Mariaenrica Tinè, Umberto Semenzato, Elisabetta Cocconcelli, Davide Biondini, Marco Damin, Marina Saetta, Manuel G. Cosio, Elisabetta Balestro, Paolo Spagnolo, Erica Bazzan, Nicol Bernardinello
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Immunology
Subjects:	extracellular vesicles interstitial lung diseases MISEV idiopathic pulmonary fibrosis lung fibrosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1541645/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Nutritional status in patients with cystic fi brosis before and after lung transplantation
by: M. Sh. Khubutiya, et al.
Published: (2017-06-01)

Swine Flu Progressive Pulmonary Fibrosis – Clinical Manifestation and Morphology of Explanted Lungs
by: Shirish Sahebrao Chandanwale, et al.
Published: (2025-04-01)

Interstitial lung diseases: a view on the problem
by: O. G. Sych, et al.
Published: (2025-06-01)

Organising Pneumonia in a Patient Following Obinutuzumab for Follicular Lymphoma
by: Viral Nanda, et al.
Published: (2025-06-01)

Percutaneous endoscopic gastrostomy in comprehensive preparing the patients with severe body mass defciency for lung transplantation
by: M. Sh. Khubutiya, et al.
Published: (2019-03-01)

Computed tomography in evaluating the development of different types of pulmonary fibrosis in patients with interstitial lung diseases
by: A. A. Speranskaya, et al.
Published: (2016-03-01)

Features of lung impairment due to COVID-19 in patients of the first wave of the pandemic (literature review)
by: Yu.I. Feshchenko, et al.
Published: (2022-12-01)

Telomere biology disorders in lung transplantation: Clinical challenges and management strategies
by: Farah Mesli, et al.
Published: (2025-08-01)

Indications for pediatric lung transplantation in 2025: A new era
by: Nicholas Avdimiretz, MD FRCPC, et al.
Published: (2025-08-01)

Secreted Phosphoprotein 1 in Lung Diseases
by: Hongli Liu, et al.
Published: (2025-05-01)

Effectiveness of photodynamic therapy of a patient with early central lung cancer and cystic fibrosis
by: E. S. Borzenko, et al.
Published: (2019-10-01)

Pulmonary Aspergillosis in Patients with Cystic Fibrosis in Russian Federation
by: Ya. I. Kozlova, et al.
Published: (2018-07-01)

Exercise improves pulmonary fibrosis and neurological symptoms via S100A12 inhibition
by: Yan Sun, et al.
Published: (2025-06-01)

Therapeutic Optimization of <i>Pseudomonas aeruginosa</i> Phages: From Isolation to Directed Evolution
by: Sara Bolognini, et al.
Published: (2025-06-01)

Lung transplantation for connective tissue disease–related interstitial lung disease: Clinical outcomes compared to idiopathic pulmonary fibrosis
by: Sarah L. Khan, MD, MHS, et al.
Published: (2025-08-01)

Mitigating the side effects of conventional radiotherapy: deep examination of the FLASH effect on human healthy bronchial epithelial cell line
by: Francesca Del Debbio, et al.
Published: (2025-01-01)

Successful treatment of vanishing bronchus intermedius syndrome following lung transplantation
by: I. V. Pashkov, et al.
Published: (2021-01-01)

Interstitial lung disease associated with systemic sclerosis in a patient with long-term employment as a marble worker
by: A. A. Chinova, et al.
Published: (2022-08-01)

Rituximab in the treatment of systemic sclerosis. Literature review
by: L. A. Garzanova
Published: (2023-08-01)

MicroRNAs as fibrosis markers in patients with hypersensitivity pneumonitis
by: G. S. Shepelkova, et al.
Published: (2024-04-01)

LUNG TRANSPLANTATION IN CYSTIC FIBROSIS PATIENT WITH CHRONIC AIRWAYS INFECTION OF BURKHOLDERIA CEPACIA (the first case in Russian Federation)
by: S. V. Gautier, et al.
Published: (2016-06-01)

Telomere Shortening in Interstitial Lung Disease: Challenges and Promises
by: Haonan Jin, et al.
Published: (2025-07-01)

Analysis of the therapeutic effect and potential mechanism of Fe3O4-polydopamine nanoparticles in enhancing mesenchymal stem cells therapy for pulmonary fibrosis
by: Xiaoming Zhao, et al.
Published: (2025-10-01)

Mechanisms of Lung Cancer Development in Cystic Fibrosis Patients: The Role of Inflammation, Oxidative Stress, and Lung Microbiome Dysbiosis
by: Raffaella Pagliaro, et al.
Published: (2025-06-01)

Difficulties in the Differential Diagnosis of Tracheobronchomegaly in Children
by: N. A. Il’ina, et al.
Published: (2020-06-01)

DORNASE ALFA IN RUSSIA: 15 YEARS LATER. EFFICACY OF THE DRUG IN THE BASIC TREATMENT IN CHILDREN WITH CYSTIC FIBROSIS
by: O. I. Simonova, et al.
Published: (2012-03-01)

From Gut to Lung: The Role of Bile Acids in Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD)
by: Shi YJ, et al.
Published: (2025-08-01)

Unmasking Hepatitis C Infection: A Case Report of Interstitial Lung Disease as a Potential Extrahepatic Manifestation
by: Zeina Morcos, et al.
Published: (2025-07-01)

Safety and efficiency of therapy with modern preparations of idiopathic pulmonary fibrosis
by: E. A. Strel’tsov
Published: (2018-03-01)

Analysis of expression profile of long non-coding RNA in patients with idiopathic and COVID-19-induced pulmonary fibrosis
by: G. F. Korytina, et al.
Published: (2023-12-01)

Improved Translational Relevance of In Vitro Fibrosis Models by Integrating IOX2-Mediated Hypoxia-Mimicking Pathways
by: Manuel A. González Hernández, et al.
Published: (2025-06-01)

Prospects of using chondroprotectors for the treatment of pulmonary pathology
by: I. Yu. Torshin, et al.
Published: (2022-01-01)

The Mechanism of Action of Follistatin-like Protein-1 (FSTL-1)
by: V. G. Kukes, et al.
Published: (2019-12-01)

Myeloperoxidase‐Antibody Positivity and Progression to Microscopic Polyangiitis in Interstitial Lung Disease: A Case Series
by: Michael Hoskins, et al.
Published: (2025-07-01)

The Effects of Different Types of Exercise on Pulmonary Inflammation and Fibrosis in Mice with Type 2 Diabetes Mellitus
by: Haoyang Gao, et al.
Published: (2025-07-01)

SENP1-Sirt3 axis regulates type II alveolar epithelial cell activity to confer resistance against oxidative damage in lung tissue
by: Mingming Zhang, et al.
Published: (2025-09-01)

Unlocking the therapeutic potential of RNA splicing in lung fibrosis: Insights from the SRSF7–PKM axis
by: Bi-Sen Ding
Published: (2025-06-01)

Idiopathic Pulmonary Fibrosis and Hypersensitive Pneumonitis: A Fresh View on The Role of Genetic and Epigenetic Factors in The Development and Course of Diseases
by: E. E. Arkhangelskaya, et al.
Published: (2024-11-01)

Non-invasive of liver fibrosis diagnostics: the role of serum markers
by: A. F. Sheptulina, et al.
Published: (2015-05-01)

The diagnostic value of indirect markers of liver fibrosis in patients with chronic hepatitis B
by: D. V. Tereshkov, et al.
Published: (2020-03-01)